Cargando…
Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence
A 56-year-old man was admitted to our hospital for urachal carcinoma with peritoneal dissemination. He received first-line chemotherapy with gemcitabine and cisplatin. After the fifth cycle, a computed tomography (CT) scan revealed abdominal fluid, and his serum tumor marker levels were increased. T...
Autores principales: | Yasui, Masato, Jikuya, Ryosuke, Tatenuma, Tomoyuki, Muraoka, Kentaro, Umemoto, Susumu, Kawai, Masaki, Kouno, Tsutomu, Kishida, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020648/ https://www.ncbi.nlm.nih.gov/pubmed/30009079 http://dx.doi.org/10.1155/2018/9836154 |
Ejemplares similares
-
Comparative effectiveness of surgery and radiotherapy for survival of patients with clinically localized prostate cancer: A population-based coarsened exact matching retrospective cohort study
por: Yasui, Masato, et al.
Publicado: (2020) -
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
por: Noguchi, Go, et al.
Publicado: (2018) -
Distinguishing between limited systemic scleroderma-associated pseudo-obstruction and peritoneal dissemination
por: Saigusa, Susumu, et al.
Publicado: (2015) -
Villous adenoma of the urachus obscuring urachal adenocarcinoma: A case report
por: Nishikawa, Yuri, et al.
Publicado: (2020) -
Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy
por: Uemura, Koichi, et al.
Publicado: (2017)